Benzinga's Top #PreMarket Losers

Esperion Therapeutics Inc ESPR shares dropped 11.32 percent to $89.15 in pre-market after falling 0.24 percent on Tuesday. Francesca's Holdings Corp FRAN shares fell 5.16 percent to $15.25 in pre-market trading. Francesca's reported Q4 earnings of $0.17 per share on revenue of $95 million. The company expected Q2 earnings of $0.81 to $0.90 per share, on revenue of $104 million to $107 million. Regeneron Pharmaceuticals Inc REGN shares declined 3.34 percent to $508.50 in pre-market trading. The FDA Panel has recommended the approval of Sanofi and Regeneron's Praluent. Gulfport Energy Corporation GPOR shares tumbled 2.82 percent to $44.09 in pre-market trading. Gulfport Energy announced an offering of 10 million common shares. bluebird bio Inc BLUE fell 2.63 percent to $181.73 in pre-market trading after dropping 1.05 percent on Tuesday.